This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Ruth C. Ellis | |
|---|---|
| Name | Ruth C. Ellis |
| Birth date | 1940s |
| Birth place | Detroit, Michigan |
| Fields | Cancer biology; molecular oncology; cell signaling |
| Workplaces | Wayne State University; Barbara Ann Karmanos Cancer Institute |
| Alma mater | Wayne State University; University of Michigan |
| Known for | Research on tumor suppressors; breast cancer biology; cellular senescence |
Ruth C. Ellis
Ruth C. Ellis is an American cancer biologist and molecular oncologist noted for work on tumor suppressor pathways, breast cancer biology, and cellular senescence. Her career has spanned academic appointments, translational research at cancer centers, and mentorship roles linking institutions such as Wayne State University, the Barbara Ann Karmanos Cancer Institute, the National Institutes of Health, and collaborations with researchers at the University of Michigan and Harvard Medical School. Ellis's work intersects themes relevant to breast cancer, tumor suppressor genes, p53, BRCA1, and signaling networks implicated in oncogenesis.
Ellis grew up in Detroit, Michigan, during a period of significant social change linked to events like the Detroit race riot of 1967 and urban development tied to the Ford Motor Company. She pursued undergraduate studies at Wayne State University and completed graduate training in cellular biology and molecular oncology, with postdoctoral work that connected her to laboratories at the National Institutes of Health and collaborative projects with researchers from Cold Spring Harbor Laboratory and the Massachusetts Institute of Technology. Her education placed her within networks including the American Association for Cancer Research, the American Society for Cell Biology, and partnerships with faculty from the University of Pennsylvania and the Johns Hopkins University School of Medicine.
Ellis held faculty positions at Wayne State University and research appointments at the Barbara Ann Karmanos Cancer Institute, where she established laboratories focused on oncogenic signaling and cell cycle regulation. She collaborated with investigators from Dana-Farber Cancer Institute, MD Anderson Cancer Center, Fred Hutchinson Cancer Research Center, and the Sloan Kettering Institute, fostering translational links between basic science and clinical oncology teams including oncologists from the American Society of Clinical Oncology network. Her laboratory utilized techniques developed at institutions such as Cold Spring Harbor Laboratory, methods refined with inputs from researchers at Stanford University School of Medicine and the University of California, San Francisco. Ellis contributed to multi-institutional consortia alongside colleagues affiliated with the National Cancer Institute, the Wellcome Trust, and the European Molecular Biology Laboratory.
Ellis's research addressed tumor suppressor pathways, cellular senescence, and the molecular determinants of breast carcinogenesis. She investigated interactions among molecules including p53, RB, BRCA1, PTEN, and signaling nodes such as PI3K/AKT pathway, MAPK/ERK pathway, and the Wnt signaling pathway, with conceptual links to processes studied in laboratories led by scientists from Harvard Medical School, Yale School of Medicine, and Columbia University Irving Medical Center. Her work applied models and techniques from groups at Salk Institute for Biological Studies, Cold Spring Harbor Laboratory, and European Molecular Biology Laboratory to dissect mechanisms of oncogene-induced senescence, chemotherapy response, and metastatic progression. Through collaborations with clinicians at the Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital, Ellis helped translate basic findings into biomarker studies and therapeutic hypotheses, intersecting with trials coordinated by the National Cancer Institute and cooperative groups such as the Alliance for Clinical Oncology Research.
Her publications engaged topics related to receptor signaling (notably studies paralleling research from Cell Press journals), the role of microenvironmental cues reminiscent of work at the Cornell University Weill Institute for Cell and Molecular Biology, and epigenetic regulation investigated in partnership with laboratories at the Broad Institute and the Scripps Research Institute. Ellis's studies influenced understanding of resistance mechanisms to targeted therapies developed at pharmaceutical collaborations with researchers from Roche, Pfizer, and Novartis.
Ellis received honors from professional organizations including the American Association for Cancer Research, the National Institutes of Health grant awards, and institutional recognitions from Wayne State University and the Barbara Ann Karmanos Cancer Institute. She was invited to present at conferences such as the AACR Annual Meeting, the Cold Spring Harbor Laboratory meetings, and symposia at Harvard Medical School and Stanford University. Her work was acknowledged by peer societies including the American Society for Cell Biology and awards associated with collaborative initiatives supported by the Wellcome Trust and the National Cancer Institute cancer centers program.
Ellis balanced her scientific career with community engagement in Detroit area initiatives and mentoring programs linked to the National Science Foundation and local STEM education efforts with partners such as Michigan State University outreach and the Detroit Institute of Arts science–education collaborations. Her legacy endures through trainees who took positions at institutions including the University of Michigan, Wayne State University, Harvard Medical School, Columbia University, Yale School of Medicine, and international centers like the European Molecular Biology Laboratory and the Francis Crick Institute. Her influence persists in ongoing research on tumor suppressors, breast cancer biology, and translational oncology at cancer centers such as MD Anderson Cancer Center and the Dana-Farber Cancer Institute.
Category:American biologists Category:Cancer researchers